bpc 157 holland and barrett BPC-157 PURE Delayed Release CJC-1295 (no DAC) (10mg) -

As a selective substrate site-targeting inhibitor of nicotinamide N-methyltransferase (NNMT) the cytosolic enzyme responsible for the methylation of nicotinamide using S-adenosylmethionine (SAM) as a methyl donor 5-Amino-1MQ is studied as a tool compound for investigating NNMT enzyme activity, NAD salvage pathway interactions, and methylation pathway dynamics in controlled in-vitro experimental systems

The characteristics below reflect commonly reported laboratory attributes and are provided for comparison only

Transparent communication about potential risks fosters trust with patients and upholds professional standards

I've been using it for 5 months now